Messenger RNA of the Histidine-Rich Glycoprotein in Breast Tumors
- Authors: Autenshlyus A.I.1,2, Brusentsov I.I.1,3, Marinkin I.O.1, Smirnova S.A.4, Rukavishnikov M.Y.4, Lyakhovich V.V.2
-
Affiliations:
- Ministry of Healthcare of the Russian Federation
- Research Institute of Molecular Biology and Biophysics
- Federal Research Center Institute of Cytology and Genetics, Siberian Branch
- JSC Vector-Best
- Issue: Vol 478, No 1 (2018)
- Pages: 37-40
- Section: Biochemistry, Biophysics, and Molecular Biology
- URL: https://journal-vniispk.ru/1607-6729/article/view/212098
- DOI: https://doi.org/10.1134/S1607672918010106
- ID: 212098
Cite item
Abstract
The content of mRNA of the histidine-rich glycoprotein (HRG), a potential marker of malignant neoplasia, which can be used in differential diagnosis of breast tumors, was determined in 110 breast tumor biopsy samples. The presence of HRG mRNA did not depend on the cancer type, on the preoperative treatment or its absence, as well as on the tumor progression stage and the presence of metastases.
About the authors
A. I. Autenshlyus
Ministry of Healthcare of the Russian Federation; Research Institute of Molecular Biology and Biophysics
Author for correspondence.
Email: lpciip@211.ru
Russian Federation, Novosibirsk, 630091; Novosibirsk, 630117
I. I. Brusentsov
Ministry of Healthcare of the Russian Federation; Federal Research Center Institute of Cytology and Genetics, Siberian Branch
Email: lpciip@211.ru
Russian Federation, Novosibirsk, 630091; Novosibirsk, 630090
I. O. Marinkin
Ministry of Healthcare of the Russian Federation
Email: lpciip@211.ru
Russian Federation, Novosibirsk, 630091
S. A. Smirnova
JSC Vector-Best
Email: lpciip@211.ru
Russian Federation, Kol’tsovo, Novosibirsk oblast, 633159
M. Yu. Rukavishnikov
JSC Vector-Best
Email: lpciip@211.ru
Russian Federation, Kol’tsovo, Novosibirsk oblast, 633159
V. V. Lyakhovich
Research Institute of Molecular Biology and Biophysics
Email: lpciip@211.ru
Russian Federation, Novosibirsk, 630117
Supplementary files
